![Henrik Arne Sprengel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henrik Arne Sprengel
Vorstandsvorsitzender bei THCinol/CBDinol CanPharma GmbH
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
David Attwood | M | - |
THCinol/CBDinol CanPharma GmbH
![]() THCinol/CBDinol CanPharma GmbH Pharmaceuticals: OtherHealth Technology Part of CanPharma GmbH /Jacker/, THCinol/CBDinol CanPharma GmbH is a German company that brings years of experience in the treatment with cannabinoids and necessary expertise to ensure a professional handling of medical cannabis. The company is based in Oranienburg, Germany. The company aims to fully unleash the potential of medical cannabis with a focus on the well-being of the patient. The company offers quality products, specialized information, and a CanPharma patient ID. The company was founded by Holger Sprengel and Henrik Arne Sprengel, with Henrik Arne Sprengel serving as CEO since incorporation. THCinol/CBDinol CanPharma was acquired by CanPharma GmbH /Jacker/ from Health House International Ltd. on November 16, 2022. | 3 Jahre |
Juan de Haro Arjona | M | - |
Global Group Kalapa SL
![]() Global Group Kalapa SL Medical/Nursing ServicesHealth Services Global Group Kalapa SL is a research and production company. It is engaged in the research and production of cosmetics and pharmacy products of cannabinoids. The company was founded on November 18, 2014 and is headquartered in Gava, Spain. | 10 Jahre |
Stefan Jacker | M | - |
THCinol/CBDinol CanPharma GmbH
![]() THCinol/CBDinol CanPharma GmbH Pharmaceuticals: OtherHealth Technology Part of CanPharma GmbH /Jacker/, THCinol/CBDinol CanPharma GmbH is a German company that brings years of experience in the treatment with cannabinoids and necessary expertise to ensure a professional handling of medical cannabis. The company is based in Oranienburg, Germany. The company aims to fully unleash the potential of medical cannabis with a focus on the well-being of the patient. The company offers quality products, specialized information, and a CanPharma patient ID. The company was founded by Holger Sprengel and Henrik Arne Sprengel, with Henrik Arne Sprengel serving as CEO since incorporation. THCinol/CBDinol CanPharma was acquired by CanPharma GmbH /Jacker/ from Health House International Ltd. on November 16, 2022. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Tony Samios | M | - | 2 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Australien | 2 | 50,00% |
Deutschland | 2 | 50,00% |
Spanien | 1 | 25,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Henrik Arne Sprengel
- Persönliches Netzwerk